The largest database of trusted experimental protocols

4 protocols using ril 6

1

Monoclonal antibody depletion and checkpoint blockade in tumor model

Check if the same lab product or an alternative is used in the 5 most similar protocols
The monoclonal anti-CD8a (clone 53–6.72; BioXCell) was administered i.p. at 500 μg every 7 days from d-1 prior to tumor injection to maintain CD8 T cell depletion. Anti-PD-ligand 1 (PD-L1; clone 10F.9G2; BioXCell), or isotype IgG2b (clone LTF-2; BioXCell) were administered by 200 μg i.p. injections, as described previously (16 (link), 17 (link)) at d-1, d0, d1 and d3 with respect to vaccine boost. Mouse rIL-6 (R&D Systems) suspended in PBS was given at 60 ng i.p. daily from d0 to d3 at boost (18 (link)).
+ Open protocol
+ Expand
2

CD4+ T Cell Activation Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells were purified from spleens of uninfected BALB/c CD45.1+ (CByJ.SJL(B6)-Ptprca/J), BALB/c and Chi3l1-/- mice using CD4 MACS L3T4 beads (Miltenyi Biotech) and stimulated for 48 hours as previously described (41 (link)) with 2.5 μg/mL plate-bound anti-CD3 (145-2C11, BioXcell) and 2.5μg/ml plate-bound anti-CD28 (37.51, eBioscience). To mimic early TFH development cells were cultured in the presence of 10 μg/ml rIL-6 (R&D) and neutralizing antibodies to IL-2 (JES6-1A12, BioXcell, 5 μg/ml and S4B6-1 BioXcell, 5 μg/mL). For CD4 T cell co-cultures, BALB/c or Chi3l-/- CD45.2+ T cells were mixed at a 1:1 ratio with CD45.1+ T cells and then stimulated for 48 hours with CD3 and CD28 antibodies.
+ Open protocol
+ Expand
3

Activation of Naïve CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD4+ cells were purified from spleens of B6 mice using positive selection with anti-CD4 MACS beads (Miltenyi Biotec). Purified cells were activated with anti-CD3 (clone 145–2C11, 2.5μg/mL) and anti-CD28 (clone 37.51, 2.5μg/mL) antibodies in the presence of the indicated concentration of anti-IL-2 neutralizing antibodies (JES6–1A12 and S4B6–1, BioXcell) with or without rIL6 (R&D) at indicated concentrations. Cells were cultured for 48 h at 37 °C in 125 μl in round- bottomed 96-well plates in RPMI-1640 supplemented with sodium pyruvate, HEPES (pH 7.2–7.6 range), nonessential amino acids, penicillin, streptomycin, 2-mercaptoethanol and 10% heat-inactivated FCS (all from Gibco).
+ Open protocol
+ Expand
4

ATDC5 Chondrocyte Maturation and IL-6 Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
ATDC5 cells (Sigma, 99072806) were maintained in DMEM/F-12 (1:1) medium (Gibco, 11330032) supplemented with 5% FBS and 1% penicillin/streptomycin. ATDC5 cells were maturated in DMEM/F-12 (1:1) medium supplemented with 5% FBS, 1% penicillin/streptomycin, 1% ITS premix (Corning, 354352), 50μg/ml ascorbic acid, 10nM dexamethasone, and 10ng/ml TGF-β3 (Sigma, SRP6552) for 5, 10, and 15 days.
Both wild type and Adgrg6 KO ATDC5 cells were treated with 100ng/ml recombinant human IL-6 protein (rIL-6) (R&D System, 206-IL) for 2 hours before protein extraction. Both wild type and Adgrg6 KO ATDC5 cells were treated with 10nM Stattic in maturation medium for 10 days before RNA extraction.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!